Cleared Traditional

K963305 - ALEXANDER BOX

K963305 is an FDA 510(k) clearance for ALEXANDER BOX, manufactured by Alexander Mfg. Co.. The device is a Class 2 Cardiovascular device with product code BWA cleared through the Traditional 510(k) pathway after a 238-day FDA review.

K963305 · Alexander Mfg. Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
238d
Days
Class 2
Risk

K963305 is an FDA 510(k) clearance for the ALEXANDER BOX, BATTERY, RECHARGEABLE. Classified as Unit, Electrosurgical And Coagulation, With Accessories (product code BWA), Class II - Special Controls.

Submitted by Alexander Mfg. Co. (Mason City, US). The FDA issued a Cleared decision on April 17, 1997 after a review of 238 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 878.4400 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Alexander Mfg. Co. devices

FDA 510(k) Submission Details - K963305

510(k) Number K963305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 1996
Decision Date April 17, 1997
Days to Decision 238 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 125d · This submission: 238d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BWA Device Classification - Class 2, Special Controls

Product Code BWA Unit, Electrosurgical And Coagulation, With Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.